The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

NKX6-2  -  NK6 homeobox 2

Homo sapiens

Synonyms: GTX, Homeobox protein NK-6 homolog B, Homeobox protein Nkx-6.2, NKX6.1, NKX6.2, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of NKX6-2

  • Cloning, expression and chromosomal location of NKX6B TO 10Q26, a region frequently deleted in brain tumors [1].
  • However, the efficacy of these GTX in treating or preventing established neutropenic sepsis remains to be established in prospective controlled clinical trials [2].
  • Infusion of G-CSF stimulated GTX results in measurable increases in the recipients' neutrophil count and may reduce the duration and severity of neutropenia [2].
  • Early studies employing steroid mobilised GTX showed variable, dose-dependent results and significant pulmonary toxicity was reported [2].
  • Bacterial meningoencephalitis occurring in the pre-engraftment period after bone marrow transplantation (BMT) is a rare complication, and the feasibility of granulocyte transfusion (GTX) in such cases remains to be elucidated [3].
 

High impact information on NKX6-2

  • Mitral valve area in GTXP patients decreased from 2.5 +/- 0.4 to 2.1 +/- 0.3 cm2 (P < .05); however, mitral valve area in PTFE patients showed no significant change during follow-up (2.1 +/- 0.4 to 2.0 +/- 0.4 cm2, P = NS) [4].
  • METHODS AND RESULTS: Between November 1986 and November 1993, 40 patients underwent mitral valve repair with artificial chordae using glutaraldehyde-tanned xenograft pericardium (GTXP) or polytetrafluoroethylene suture (PTFE) [4].
  • Both glutaraldehyde-tanned xenograft pericardial chordae (GTXP) and extruded polytetrafluorethylene chordae (ePTFE) heal to papillary muscles and cusps [5].
  • Wild-type channels from skeletal muscle (mu 1) were more sensitive to GTX modification than wild-type cardiac channels (rH1) by a factor of 1 [6].
  • Introduction of specific mutations into a synthetic internal ribosome entry site (IRES(GTX)) derived from the GTX homeodomain protein revealed additional transcriptional activity [7].
 

Chemical compound and disease context of NKX6-2

  • Results using pure concentrations of a sodium channel-specific toxin could be detected to inhibit hemolysis at a concentration of 0.3 microg/ml STX, 3.5 microg/ml for neo-STX, 3.0 microg/ml for GTX, and 5.0 microgl for TTX in the presence of ouabain and veratridine [8].
  • Before GTX, all patients had fever despite antibiotic and antimycotic therapy, neutropenia (absolute neutrophil count ANC < 500/microl), increasing C-reactive protein (CRP) values, hypotension requiring dopamine infusion and three patients needed supplemental oxygen [9].
  • The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX [10].
  • On the other hand, spermine did not effect the growth of A. minutum T1, though it decreased the cell toxicity and the ratio of GTX 2 + GTX 3 (15.0 +/- 6.6%) [11].
 

Biological context of NKX6-2

 

Anatomical context of NKX6-2

  • A rapid increase of granulocytes in CSF was also observed, and cultures of blood and CSF became negative after GTX [3].
  • Further studies are warranted to evaluate the clinical efficacy of GTX for the treatment of uncontrolled infections in granulocytopenic stem cell transplant recipients [3].
  • CONCLUSION: Two necessary elements in the design of future trials of therapeutic GTX should be the transfusion of high doses of granulocytes and the provision of leukocytes that are crossmatch-compatible with the recipient's serum [14].
 

Associations of NKX6-2 with chemical compounds

  • Toxin profiles of shellfish showed approximately the same composition as that of the dinoflagellate, although the shellfish contained several carbamate toxins (GTX I, GTX II, GTX IV and NEO) that were not detected in G. catenatum culture extracts [15].
 

Analytical, diagnostic and therapeutic context of NKX6-2

  • Northern blot experiments showed that NKX6B expression is tightly controlled in a tissue-specific fashion with the highest site of expression being the brain [1].
  • The expressed channels were measured using whole-cell patch-clamp techniques and examined for GTX sensitivity [6].
  • Selected isolates from groups demonstrating 90% similarity were screened for their ability to metabolize a range of PST (gonyautoxins 1 and 4 [GTX 1/4], GTX 2/3, GTX 5, saxitoxin, and neosaxitoxin) using a novel screening method and confirming its results by high-performance liquid chromatography [16].
  • We conducted a prospective, non-randomized study of granulocyte transfusions (GTX) to control acute life-threatening infections (44 episodes) and to prevent recurrence of severe fungal infections during HCT or intensive chemotherapy (23 episodes) [17].
  • BACKGROUND: Meta-analysis was used to explain disagreements across controlled clinical studies of the efficacy of granulocyte transfusions (GTX) in the treatment of bacterial sepsis [18].

References

  1. Cloning, expression and chromosomal location of NKX6B TO 10Q26, a region frequently deleted in brain tumors. Lee, S.H., Davison, J.A., Vidal, S.M., Belouchi, A. Mamm. Genome (2001) [Pubmed]
  2. Granulocyte transfusions in the G-CSF era. Where do we stand? Robinson, S.P., Marks, D.I. Bone Marrow Transplant. (2004) [Pubmed]
  3. Granulocyte transfusion as a treatment for enterococcal meningoencephalitis after allogeneic bone marrow transplantation from an unrelated donor. Tsukada, Y., Nagayama, H., Mori, T., Shimizu, T., Sato, N., Takayama, N., Ishida, A., Handa, M., Ikeda, Y., Okamoto, S. Bone Marrow Transplant. (2003) [Pubmed]
  4. Mitral valve dysfunction resulting from thickening and stiffening of artificial mitral valve chordae. Kobayashi, Y., Nagata, S., Ohmori, F., Eishi, K., Miyatake, K. Circulation (1996) [Pubmed]
  5. Chordal replacement in mitral valve repair. Frater, R.W., Vetter, H.O., Zussa, C., Dahm, M. Circulation (1990) [Pubmed]
  6. Novel site on sodium channel alpha-subunit responsible for the differential sensitivity of grayanotoxin in skeletal and cardiac muscle. Kimura, T., Yamaoka, K., Kinoshita, E., Maejima, H., Yuki, T., Yakehiro, M., Seyama, I. Mol. Pharmacol. (2001) [Pubmed]
  7. A novel synthetic mammalian promoter derived from an internal ribosome entry site. Hartenbach, S., Fussenegger, M. Biotechnol. Bioeng. (2006) [Pubmed]
  8. A rapid hemolysis assay for the detection of sodium channel-specific marine toxins. Shimojo, R.Y., Iwaoka, W.T. Toxicology (2000) [Pubmed]
  9. Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection. Grigull, L., Schrauder, A., Schmitt-Thomssen, A., Sykora, K., Welte, K. Infection (2002) [Pubmed]
  10. The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX. Fogelman, D.R., Chen, J., Chabot, J.A., Allendorf, J.D., Schrope, B.A., Ennis, R.D., Schreibman, S.M., Fine, R.L. Surg. Oncol. Clin. N. Am. (2004) [Pubmed]
  11. Effects of exogenous polyamines on growth, toxicity, and toxin profile of dinoflagellate Alexandrium minutum. Hwang, D.F., Lu, Y.H., Noguchi, T. Shokuhin Eiseigaku Zasshi (2003) [Pubmed]
  12. Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Przyborski, S.A., Smith, S., Wood, A. Stem Cells (2003) [Pubmed]
  13. Kinetics of grayanotoxin evoked modification of sodium channels in squid giant axons. Yakehiro, M., Seyama, I., Narahashi, T. Pflugers Arch. (1997) [Pubmed]
  14. Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. Vamvakas, E.C., Pineda, A.A. Journal of clinical apheresis. (1997) [Pubmed]
  15. Paralytic shellfish poisoning in northwest Spain: the toxicity of the dinoflagellate Gymnodinium catenatum. Anderson, D.M., Sullivan, J.J., Reguera, B. Toxicon (1989) [Pubmed]
  16. Biotransformations of paralytic shellfish toxins by bacteria isolated from bivalve molluscs. Smith, E.A., Grant, F., Ferguson, C.M., Gallacher, S. Appl. Environ. Microbiol. (2001) [Pubmed]
  17. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Mousset, S., Hermann, S., Klein, S.A., Bialleck, H., Duchscherer, M., Bomke, B., Wassmann, B., Böhme, A., Hoelzer, D., Martin, H. Ann. Hematol. (2005) [Pubmed]
  18. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. Vamvakas, E.C., Pineda, A.A. Journal of clinical apheresis. (1996) [Pubmed]
 
WikiGenes - Universities